CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)	Total	Common Stock	Additional Paid in Capital	Accumulated Deficit	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2021		11,626,522
Beginning balance at Dec. 31, 2021	$ 45,173,173	$ 11,627	$ 78,425,081	$ (25,580,045)	$ (7,683,490)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,099,938)
Ending balance (in shares) at Mar. 31, 2022		11,627,528
Ending balance at Mar. 31, 2022	41,210,855	$ 11,628	79,335,877	(26,679,983)	(11,456,667)
Beginning balance (in shares) at Dec. 31, 2021		11,626,522
Beginning balance at Dec. 31, 2021	45,173,173	$ 11,627	78,425,081	(25,580,045)	(7,683,490)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(1,978,123)
Ending balance (in shares) at Jun. 30, 2022		11,911,043
Ending balance at Jun. 30, 2022	44,766,664	$ 11,911	83,769,588	(27,558,168)	(11,456,667)
Beginning balance (in shares) at Dec. 31, 2021		11,626,522
Beginning balance at Dec. 31, 2021	45,173,173	$ 11,627	78,425,081	(25,580,045)	(7,683,490)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(9,462,762)
Ending balance (in shares) at Sep. 30, 2022		11,948,718
Ending balance at Sep. 30, 2022	35,704,682	$ 11,949	82,375,477	(35,042,807)	(11,639,937)
Beginning balance (in shares) at Dec. 31, 2021		11,626,522
Beginning balance at Dec. 31, 2021	45,173,173	$ 11,627	78,425,081	(25,580,045)	(7,683,490)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	2,571,785		2,571,785
Common stock repurchased	(4,362,052)				(4,362,052)
Stock issuance related to acquisition and contingent consideration (in shares)		555,390
Issuance of contingent consideration shares originally incorrectly recorded in Q2 2023	3,164,967	$ 555	3,164,412
Stock issued in conversion of warrants (in shares)		18,196
Stock issued in conversion of warrants	0	$ 18	(18)
Stock grant program vesting (in shares)		87,441
Stock grant program vesting	$ 0	$ 87	(87)
Stock options exercised (in shares)	4,555	4,555
Stock options exercised	$ 28,797	$ 5	28,792
Net loss	$ (15,254,676)
Ending balance (in shares) at Dec. 31, 2022	10,842,271	12,292,104
Ending balance at Dec. 31, 2022	$ 31,321,994	$ 12,292	84,189,965	(40,834,721)	(12,045,542)
Beginning balance (in shares) at Mar. 31, 2022		11,627,528
Beginning balance at Mar. 31, 2022	41,210,855	$ 11,628	79,335,877	(26,679,983)	(11,456,667)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(878,185)
Ending balance (in shares) at Jun. 30, 2022		11,911,043
Ending balance at Jun. 30, 2022	44,766,664	$ 11,911	83,769,588	(27,558,168)	(11,456,667)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(7,484,639)
Ending balance (in shares) at Sep. 30, 2022		11,948,718
Ending balance at Sep. 30, 2022	$ 35,704,682	$ 11,949	82,375,477	(35,042,807)	(11,639,937)
Beginning balance (in shares) at Dec. 31, 2022	10,842,271	12,292,104
Beginning balance at Dec. 31, 2022	$ 31,321,994	$ 12,292	84,189,965	(40,834,721)	(12,045,542)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(5,251,201)
Ending balance (in shares) at Mar. 31, 2023		12,452,613
Ending balance at Mar. 31, 2023	$ 26,742,353	$ 12,452	84,861,365	(46,085,922)	(12,045,542)
Beginning balance (in shares) at Dec. 31, 2022	10,842,271	12,292,104
Beginning balance at Dec. 31, 2022	$ 31,321,994	$ 12,292	84,189,965	(40,834,721)	(12,045,542)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(11,015,110)
Ending balance (in shares) at Jun. 30, 2023		13,056,409
Ending balance at Jun. 30, 2023	$ 22,893,674	$ 13,056	86,775,991	(51,849,831)	(12,045,542)
Beginning balance (in shares) at Dec. 31, 2022	10,842,271	12,292,104
Beginning balance at Dec. 31, 2022	$ 31,321,994	$ 12,292	84,189,965	(40,834,721)	(12,045,542)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(14,837,232)
Ending balance (in shares) at Sep. 30, 2023		13,120,413
Ending balance at Sep. 30, 2023	$ 19,870,965	$ 13,120	87,575,340	(55,671,953)	(12,045,542)
Beginning balance (in shares) at Dec. 31, 2022	10,842,271	12,292,104
Beginning balance at Dec. 31, 2022	$ 31,321,994	$ 12,292	84,189,965	(40,834,721)	(12,045,542)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	2,199,046		2,199,046
Stock issuance related to acquisition and contingent consideration (in shares)		833,357
Issuance of contingent consideration shares originally incorrectly recorded in Q2 2023	1,820,857	$ 898	1,819,959
Stock grant program vesting (in shares)		397,208
Stock grant program vesting	0	$ 333	(333)
Issuance of warrants	$ 181,119		181,119
Stock options exercised (in shares)	0
Net loss	$ (25,437,661)
Ending balance (in shares) at Dec. 31, 2023	12,072,836	13,522,669
Ending balance at Dec. 31, 2023	$ 10,085,355	$ 13,523	88,389,756	(66,272,382)	(12,045,542)
Beginning balance (in shares) at Mar. 31, 2023		12,452,613
Beginning balance at Mar. 31, 2023	26,742,353	$ 12,452	84,861,365	(46,085,922)	(12,045,542)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(5,763,909)
Ending balance (in shares) at Jun. 30, 2023		13,056,409
Ending balance at Jun. 30, 2023	22,893,674	$ 13,056	86,775,991	(51,849,831)	(12,045,542)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(3,822,122)
Ending balance (in shares) at Sep. 30, 2023		13,120,413
Ending balance at Sep. 30, 2023	$ 19,870,965	$ 13,120	$ 87,575,340	$ (55,671,953)	$ (12,045,542)